<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang M</submitter><funding>national natural science foundation of china</funding><funding>jiangsu province’s key discipline of medicine</funding><funding>the priority academic program development of jiangsu higher education institutions</funding><pagination>116</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8684143</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Triple-negative breast cancer (TNBC) is highly metastatic and lethal. Due to a lack of druggable targets for this disease, there are no effective therapies in the clinic.&lt;h4>Methods&lt;/h4>We used TNBC cells and xenografted mice as models to explore triptonide-mediated inhibition of TNBC metastasis and tumor growth. Colony formation assay was used to quantify the tumorigenesis of TNBC cells. Wound-healing and cell trans-well assays were utilized to measure cell migration and invasion. Tube formation assay was applied to access tumor cell-mediated vasculogenic mimicry. Western blot, quantitative-PCR, immunofluorescence imaging, and immunohistochemical staining were used to measure the expression levels of various tumorigenic genes in TNBC cells.&lt;h4>Results&lt;/h4>Here, we showe</pubmed_abstract><journal>Breast cancer research : BCR</journal><pubmed_title>Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.</pubmed_title><pmcid>PMC8684143</pmcid><funding_grant_id>XK201118</funding_grant_id><funding_grant_id>No.81902647</funding_grant_id><funding_grant_id>No.82073225</funding_grant_id><funding_grant_id>No. 81703595</funding_grant_id><funding_grant_id>No. 81772535</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Qiao Y</pubmed_authors><pubmed_authors>Qi J</pubmed_authors><pubmed_authors>Hu Y</pubmed_authors><pubmed_authors>Lu W</pubmed_authors><pubmed_authors>Xu P</pubmed_authors><pubmed_authors>Zhou Q</pubmed_authors><pubmed_authors>Meng M</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Zhao Z</pubmed_authors><pubmed_authors>Zhou Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.</name><description>&lt;h4>Background&lt;/h4>Triple-negative breast cancer (TNBC) is highly metastatic and lethal. Due to a lack of druggable targets for this disease, there are no effective therapies in the clinic.&lt;h4>Methods&lt;/h4>We used TNBC cells and xenografted mice as models to explore triptonide-mediated inhibition of TNBC metastasis and tumor growth. Colony formation assay was used to quantify the tumorigenesis of TNBC cells. Wound-healing and cell trans-well assays were utilized to measure cell migration and invasion. Tube formation assay was applied to access tumor cell-mediated vasculogenic mimicry. Western blot, quantitative-PCR, immunofluorescence imaging, and immunohistochemical staining were used to measure the expression levels of various tumorigenic genes in TNBC cells.&lt;h4>Results&lt;/h4>Here, we showe</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-05-07T21:17:34.576Z</modification><creation>2022-02-11T14:11:13.243Z</creation></dates><accession>S-EPMC8684143</accession><cross_references><pubmed>34922602</pubmed><doi>10.1186/s13058-021-01488-7</doi></cross_references></HashMap>